MedTrace Logo

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

NCT03292965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-10-09

No results posted yet for this study

Summary

Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring

Conditions

  • Neuromuscular Block, Residual

Interventions

DRUG

Neostigmine

Referring to the randomisation allocation program, participants allocated to group neostigmine, administrate neostigmine as reversal

DRUG

Sugammadex

Referring to the randomisation allocation program, participants allocated to group sugammadex, administrate sugammadex as reversal

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • AhYoung Oh, M.D Ph. D · Department of anesthesiology and pain medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-28
Primary Completion
2017-11-29
Completion
2017-11-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03292965 on ClinicalTrials.gov